Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of the Peripheral Nervous System : JPNS
|
February 1, 2023
B-cell and T-cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study
G G A van Lieverloo, A Al-Soudi, L Wieske, et al.
Journal of Neurology
|
June 26, 2021
Clinical outcome of CIDP one year after start of treatment: a prospective cohort study
S R M Bus, M C Broers, I M Lucke, et al.
Journal of the Peripheral Nervous System : JPNS
|
March 12, 2026
CIDP With and Without Monoclonal Gammopathy of Undetermined Significance (MGUS): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response
R van Veen, A E Baars, I N van Doorn, et al.
Multiple Sclerosis and Related Disorders
|
November 30, 2021
Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
Z L E van Kempen, L Wieske, E W Stalman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of the Peripheral Nervous System : JPNS
|
February 1, 2023
B-cell and T-cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study
G G A van Lieverloo, A Al-Soudi, L Wieske, et al.
Journal of Neurology
|
June 26, 2021
Clinical outcome of CIDP one year after start of treatment: a prospective cohort study
S R M Bus, M C Broers, I M Lucke, et al.
Journal of the Peripheral Nervous System : JPNS
|
March 12, 2026
CIDP With and Without Monoclonal Gammopathy of Undetermined Significance (MGUS): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response
R van Veen, A E Baars, I N van Doorn, et al.
Multiple Sclerosis and Related Disorders
|
November 30, 2021
Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
Z L E van Kempen, L Wieske, E W Stalman, et al.
Page
of 2